Finance

Lists
EMAMILTD:NSE
Emami Ltd
₹413,10
+1,23%
(+5,00) 1D
16 Nov., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for EMAMILTD...
Open
₹409,00
High
₹414,75
Low
₹403,55
Mkt. cap
178,66 mjd
Avg. vol.
921,58 k
Volume
505,84 k
Dividend
2,66%
Quarterly dividend
₹2,75
Ex-dividend date
13 Nov. 2026
P/E ratio
24,23
52-wk high
₹550,90
52-wk low
₹357,00
EPS
₹17,05
Shares outstanding
453,94 m
No. of employees
3 k
Open
₹409,00
High
₹414,75
Low
₹403,55
Mkt. cap
178,66 mjd
Avg. vol.
921,58 k
Volume
505,84 k
Dividend
2,66%
Quarterly dividend
₹2,75
Ex-dividend date
13 Nov. 2026
P/E ratio
24,23
52-wk high
₹550,90
52-wk low
₹357,00
EPS
₹17,05
Shares outstanding
453,94 m
No. of employees
3 k
News stories
From web sources and news partners
Profile
Emami Group is an Indian multinational conglomerate headquartered in Kolkata. The company caters to a number of niche categories in the personal care and healthcare segments. The company's products are sold across 60+ nations and are available in 4.5 million retail outlets across India. The company has seven manufacturing units across India and one overseas unit. Among its prominent brands is an antiseptic cream named BoroPlus. The company's skin care division generated an overall revenue of ₹2,655 crores in the financial year 2019–20 with an annual profit of ₹639 crores. The total group revenue of the company stands at ₹20,000 crores. Wikipedia
About Emami Ltd
CEOSudhakar Rao Desai
Employees3,1 k
Founded1974
Headquarters-
SectorConsumer Staples
IndustryPersonal care products
Last report
05 Nov. 2026
Fiscal period
Q2 2027
₹3,66 / ₹3,41
+7,33%beat
Revenue / Est. (INR)
10,88 mjd / 9,87 mjd
+10,23%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Des. 2025
Mrt. 2026
Jun. 2026
Sep. 2026
Revenue
11,52 mjd
9,25 mjd
10,39 mjd
10,88 mjd
Cost of goods sold
3,38 mjd
3,31 mjd
3,55 mjd
3,72 mjd
Cost of revenue
3,38 mjd
3,31 mjd
3,55 mjd
3,72 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,13 mjd
3,42 mjd
3,39 mjd
3,56 mjd
Operating expense
4,75 mjd
4,43 mjd
5,01 mjd
5,39 mjd
Total operating expenses
8,13 mjd
7,74 mjd
8,56 mjd
9,11 mjd
Operating income
3,39 mjd
1,51 mjd
1,83 mjd
1,77 mjd
Other non operating income
189,70 m
-592,95 m
185,00 m
229,50 m
EBT including unusual items
3,45 mjd
1,64 mjd
1,95 mjd
1,94 mjd
EBT excluding unusual items
3,55 mjd
1,21 mjd
1,95 mjd
1,94 mjd
Income tax expense
255,70 m
208,99 m
557,70 m
481,20 m
Effective tax rate
7,41%
12,74%
28,64%
24,85%
Other operating expenses
1,17 mjd
588,30 m
1,19 mjd
1,38 mjd
Net income
3,19 mjd
1,43 mjd
1,37 mjd
1,44 mjd
Net profit margin
27,74%
15,48%
13,22%
13,25%
Earnings per share
7,54
3,67
3,46
3,66
Interest and investment income
-
321,25 m
-
-
Interest expense
-29,20 m
-31,50 m
-56,10 m
-60,80 m
Net interest expenses
-29,20 m
289,75 m
-56,10 m
-60,80 m
Depreciation and amortization charges
222,80 m
226,62 m
239,90 m
245,30 m
EBITDA
3,79 mjd
1,91 mjd
2,23 mjd
2,16 mjd
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google-programme